InforMax (inmx) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : InforMax (inmx)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Paul Lee who started this subject	7/2/2001 9:26:51 AM
From: Paul Lee	of 18

July 2, 2001 Research Reports Informax (INMX-NNM) by Punk Ziegel (6.70, June 13) Informax is a leading provider of bioinformatics solutions to the life-sciences industry. Its customer base includes 23 of the top 25 pharmaceutical companies, as well as leading research centers. The company has generated 100% annual growth in its bookings over the past six years as it's benefited from strong product-development activities, an experienced and well-managed sales force and favorable industry trends. We rate the shares a Buy for risk-tolerant investors and have established a 12-18-month price target of $15 per share.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next